European Cancer Forum 2025: Innovation, Security and Sustainability
Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
HER2CLIMB-05 Trial at SABCS 2025: Tucatinib Plus HP as First-Line Maintenance in HER2-Positive Metastatic Breast Cancer
Douglas Flora: The End of Cut, Poison and Burn - How AI is Rewriting Cancer Care
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Stephanie Weiner: U.S. Medical School Enrollment Surpasses 100,000 for the First Time
The ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28, 2026, at 18:30 CET (Central European Time). Register.
The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management, including screening, prevention, diagnosis, and the standard of care for early, locally advanced, recurrent, and metastatic disease. The event is scheduled for February 5–6, 2026, in Cape Town, South […]
The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town, South Africa, from 6 to 8 February 2026, […]
The Real World Data and Digital Oncology webinar, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework. The live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]
The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion […]
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]
The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […]
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […]
The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development. The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The […]
The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.” This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the […]
The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […]